The Neural Zoomer Plus™ panel offers an expanded test to detect 48 of the most common autoantibodies associated with neurological autoimmunity and cognitive decline. The Vibrant Neural Zoomer Plus™ aims to reduce the prevalence of neurological conditions by empowering patients and physicians with a vital resource for early risk detection of neurodegeneration and an enhanced focus on personalized primary prevention.